Follow
Sam Olechnowicz
Title
Cited by
Cited by
Year
The transcription factor encyclopedia
D Yusuf, SL Butland, MI Swanson, E Bolotin, A Ticoll, WA Cheung, ...
Genome biology 13, 1-25, 2012
1302012
Contributions of the host microenvironment to cancer-induced bone disease
SWZ Olechnowicz, CM Edwards
Cancer research 74 (6), 1625-1631, 2014
962014
Diet-induced obesity promotes a myeloma-like condition in vivo
ST Lwin, SWZ Olechnowicz, JA Fowler, CM Edwards
Leukemia 29 (2), 507-510, 2015
642015
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
S Gooding, SWZ Olechnowicz, EV Morris, AE Armitage, J Arezes, J Frost, ...
Nature communications 10 (1), 4533, 2019
472019
Hypoxic induction of the regulator of G-protein signalling 4 gene is mediated by the hypoxia-inducible factor pathway
SWZ Olechnowicz, AO Fedele, DJ Peet
Public Library of Science 7 (9), e44564, 2012
252012
Small animal video tracking for activity and path analysis using a novel open-source multi-platform application (AnimApp)
SR Rao, SWZ Olechnowicz, P Krätschmer, JEC Jepson, CM Edwards, ...
Scientific reports 9 (1), 12343, 2019
222019
Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment
SWZ Olechnowicz, MM Weivoda, ST Lwin, SK Leung, S Gooding, ...
Scientific reports 9 (1), 14189, 2019
142019
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
B Gámez, EV Morris, SWZ Olechnowicz, S Webb, JR Edwards, A Sowman, ...
Translational Oncology 15 (1), 101301, 2022
62022
Animal models of multiple myeloma
SWZ Olechnowicz, CM Edwards
Bone Research Protocols, 349-360, 2019
32019
Preventative metformin treatment increases myeloma tumour burden and bone disease in vivo
B Gamez, EV Morris, SWZ Olechnowicz, A Sowman, CJ Turner, ...
Bone Reports 13, 100681, 2020
2020
Cholesterol promotes myeloma cell viability and increases bone marrow myeloma tumour burden in vivo
B Gamez, EV Morris, SWZ Olechnowicz, S Aneka, CJ Turner, ST Lwin, ...
Bone Reports 13, 100331, 2020
2020
Cholesterol promotes myeloma cell viability and increases bone marrow myeloma tumour burden in vivo
G Beatriz, ST Lwin, EV Morris, CJ Turner, SWZ Olechnowicz, S Aneka, ...
JOURNAL OF BONE AND MINERAL RESEARCH 34, 198-198, 2019
2019
Pretreatment with the antidiabetic drug metformin alters the bone microenvironment to increase myeloma tumour burden and bone disease in vivo
B Gamez, EV Morris, CJ Turner, SWZ Olechnowicz, A Sowman, ...
JOURNAL OF BONE AND MINERAL RESEARCH 34, 197-197, 2019
2019
Transcriptome Profiling of the Myeloma-Bone Niche Identifies BMP Signaling Role in Bone Destruction and Niche Maintenance, and Potential As a Therapeutic Target
S Gooding, S Webb, S Olechnowicz, S Lwin, A Armitage, K Ramasamy, ...
Blood 128 (22), 483, 2016
2016
Inhibition of BMP signalling reduces bone destruction and impacts niche maintenance in a mouse model of multiple myeloma
S Gooding, S Webb, S Olechnowicz, S Lwin, A Armitage, K Ramasamy, ...
Bone Abstracts 5, 2016
2016
Diet-induced obesity promotes a myeloma-like disorder in vivo.
S Lwin, S Olechnowicz, J Fowler, C Edwards
JOURNAL OF BONE AND MINERAL RESEARCH 29, S372-S372, 2014
2014
The Pain Mediator NGF is Induced by Multiple Myeloma in vivo, and Relieved by Therapeutic Activation of Adiponectin Signalling.
S Olechnowicz, M Weivoda, S Lwin, J Edwards, C Edwards
JOURNAL OF BONE AND MINERAL RESEARCH 29, S234-S234, 2014
2014
Regulation of the Rgs4 gene by the hypoxia inducible factors.
S Olechnowicz
2012
Hypoxic Induction of the Regulator of G-Protein Signalling 4 Gene Is Mediated by the Hypoxia-Inducible
SWZ Olechnowicz, AO Fedele, DJ Peet
2012
Homo sapiens endothelial PAS domain protein
SWZ Olechnowicz, DJ Peet
Homo, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–20